119 related articles for article (PubMed ID: 25204222)
1. Anti-inflammatory and anti-proliferative effects of CBS3830 in arterialized vein grafts in rats.
Zhao ZW; Abendroth DK; Zhou ZC; Liu YZ; Pan FM; Ge JJ
Immunopharmacol Immunotoxicol; 2014 Dec; 36(6):397-403. PubMed ID: 25204222
[TBL] [Abstract][Full Text] [Related]
2. p38 MAPK inhibitor, CBS3830 limits vascular remodelling in arterialised vein grafts.
Ge JJ; Zhao ZW; Zhou ZC; Wu S; Zhang R; Pan FM; Abendroth DK
Heart Lung Circ; 2013 Sep; 22(9):751-8. PubMed ID: 23523564
[TBL] [Abstract][Full Text] [Related]
3. Vein graft arterialization causes differential activation of mitogen-activated protein kinases.
Saunders PC; Pintucci G; Bizekis CS; Sharony R; Hyman KM; Saponara F; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
J Thorac Cardiovasc Surg; 2004 May; 127(5):1276-84. PubMed ID: 15115983
[TBL] [Abstract][Full Text] [Related]
4. Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting.
Dai L; Gao M; Gu C; Zhang F; Yu Y
Eur J Cardiothorac Surg; 2016 Feb; 49(2):675-81. PubMed ID: 25838460
[TBL] [Abstract][Full Text] [Related]
5. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.
Wang X; Diao Y; Zhang H; Huo X; Zhang Q
Ann Vasc Surg; 2009 Mar; 23(2):246-54. PubMed ID: 19110400
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of intimal proliferation after vein grafting by chitosan nanoparticle with proliferation cell nuclear antigen-antisense oligo deoxy nucleotides].
Chen Z; Zhang H; Xia J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec; 21(12):1348-54. PubMed ID: 18277682
[TBL] [Abstract][Full Text] [Related]
7. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
[TBL] [Abstract][Full Text] [Related]
8. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
[TBL] [Abstract][Full Text] [Related]
9. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
[TBL] [Abstract][Full Text] [Related]
10. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
12. Prevention of intimal hyperplasia by single-dose pre-insertion external radiation in canine-vein interposition grafts.
Ulus AT; Tütün U; Zorlu F; Can C; Apaydin N; Karacagil S; Katircioğlu SF; Bayazit M
Eur J Vasc Endovasc Surg; 2000 May; 19(5):456-60. PubMed ID: 10828224
[TBL] [Abstract][Full Text] [Related]
13. Ramipril and experimental vein graft intimal hyperplasia.
Davies MG; Klyachkin ML; Barber L; Svendsen E; Hagen PO
Angiology; 1995 Feb; 46(2):91-7. PubMed ID: 7702205
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone prevents intimal hyperplasia in experimental rabbit vein grafts.
Morisaki K; Shibata R; Takahashi N; Ouchi N; Maehara Y; Murohara T; Komori K
J Vasc Surg; 2011 Dec; 54(6):1753-9. PubMed ID: 21890304
[TBL] [Abstract][Full Text] [Related]
15. Small interfering RNA targeting nuclear factor kappa B to prevent vein graft stenosis in rat models.
Meng XB; Bi XL; Zhao HL; Feng JB; Zhang JP; Song GM; Sun WY; Bi YW
Transplant Proc; 2013; 45(6):2553-8. PubMed ID: 23953580
[TBL] [Abstract][Full Text] [Related]
16. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
[TBL] [Abstract][Full Text] [Related]
17. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
18. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
[TBL] [Abstract][Full Text] [Related]
19. Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft.
Maekawa T; Komori K; Morisaki K; Itoh T
J Vasc Surg; 2012 Dec; 56(6):1689-97. PubMed ID: 22857809
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory Effect of TLR4 Gene Silencing on Intimal Hyperplasia of Vein Grafting.
Zhu Z; Xu R; Zheng X; Wang T; Li D; Wang Y; Liu K
Vasc Endovascular Surg; 2016 Oct; 50(7):464-469. PubMed ID: 27681173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
